Market Recap — October 19, 2026
Recap of insider activity, SEC filings, and market-moving news for October 19, 2026.
Last generated Oct 23, 2026, 2:11 PM ET
Top Importance Today
Filings and news with the highest AI-ranked importance score.
Nasdaq Moves to Delist Stardust Power on October 23; CFO Resigns Same Day
Cambium Sells Last Business to Univastu for $5.1M; Warns Shareholders of Complete Loss
Merck KGaA to Acquire Silence Therapeutics for $20.00/ADS in $1.3B All-Cash Deal
Merck KGaA to Acquire Silence Therapeutics in Takeover Deal
Silgan Files Definitive Trivium Deal: $1.025B AIP Partner, $4.9B MetalCo Debt, 60/40 Venture
Nexpu Closes $28M Regulation S Unit Placement at $0.70, Roughly Half Today's Price
Tradeweb Pays $1.97B for Trumid to Own the Full Credit Bond Lifecycle
Emera Files Full Merger-of-Equals Agreement With ATCO and Canadian Utilities
Copart Closes $1.8B ACV Auctions Buyout; ACV to Delist From NYSE
Zeta Network Group 20-F: $157.5M FY26 Loss, Going Concern Warning, $114M SolvBTC Impairment
Lenders Float C$2.3B Rescue to Pull Telesat Back From December Default
Cleveland-Cliffs Beats on Q3 EPS, Guides Q4 EBITDA to $715M and 2027 Above $4B
Largest Open-Market Insider Buys
Form 4 open-market purchases ranked by dollar amount.
Largest Open-Market Insider Sells
Form 4 open-market sales ranked by dollar amount.
Notable 8-Ks and News
Material events and breaking news with importance score 6 or higher.
Nasdaq Moves to Delist Stardust Power on October 23; CFO Resigns Same Day
Cambium Sells Last Business to Univastu for $5.1M; Warns Shareholders of Complete Loss
Merck KGaA to Acquire Silence Therapeutics for $20.00/ADS in $1.3B All-Cash Deal
Merck KGaA to Acquire Silence Therapeutics in Takeover Deal
Silgan Files Definitive Trivium Deal: $1.025B AIP Partner, $4.9B MetalCo Debt, 60/40 Venture
Tradeweb Pays $1.97B for Trumid to Own the Full Credit Bond Lifecycle
Copart Closes $1.8B ACV Auctions Buyout; ACV to Delist From NYSE
Lenders Float C$2.3B Rescue to Pull Telesat Back From December Default
Cleveland-Cliffs Beats on Q3 EPS, Guides Q4 EBITDA to $715M and 2027 Above $4B
EyePoint Cuts 53% of Staff, Ends Wet AMD Trials After Second Phase 3 Failure
Form 144 Notices
Notices that restricted shares may be sold soon — often a precursor to insider selling.
Day boundary: 00:00 ET (America/New_York). Filings accepted late may appear in the next day's recap.